C&O Pharmaceutical Technology (Holdings) Limited was merged into Ping An-Shionogi Co., Ltd.
2021
2020
A joint venture of Ping An-Shionogi Co., Ltd. was established by Shionogi (Hong Kong) Co., Ltd. and Ping An Life Insurance Company of China, Ltd. in Shanghai in November, 2020.
March，Ping An Insurance (Group) Company of China, Ltd. took a stake in Shionogi & Co. Ltd. becoming its seventh largest shareholder.
2020
2019
Shionogi became the controlling shareholder with shareholding of 100% held in C&O.
2019
2015
Construction for C&O’s new production base was completed and put into use.
2015
2014
C&O launched the first “Injection of Rabeprazole Sodium - Aobo Ping®” in China, which is the independently developed product.
2014
2011
Shionogi became the controlling shareholder of C&O.
C&O was appointed as the exclusive distributor of Flumarin® in China by Shionogi.
2011
2010
Sumitomo became the strategic shareholder with shareholding of 29% held in C&O.
2010
2008
Acquired 100% shareholding in Nanjing Xinaokang
Established the joint venture with XenoBiotic Laboratories, Inc., a principal contract research service provider in the United States
2008
2007
C&O was appointed as the distributor of the new generation cephalosporin antibiotics, ”Meiact” for the whole of China by Shantou Meiji Pharmaceuticals Co., Ltd.
C&O was appointed as the exclusive distributor of “Europharm cough syrup for children - Pholcotussin” in China by Europharm Laboratories Co. Ltd.
2007
2006
Acquired 100% shareholding in Shenzhen Liancheng
Acquired 69.98% shareholding in Shanghai Sun-sail
2006
2001
Acquired 100% shareholding in Nanjing Chang Ao
Nanjing Chang Ao established the research and development center to conduct the relevant activities for C&O.
Nanjing Chang Ao obtained the GMP certification by the SFDA.
Pharmaceutical Laboratories Limited.
2001
2000
Expanded the Freeze-dried Powder Workshop, Ointment and Cream Workshops
2000
1999
Expanded the pharmaceutical center, including the tablets and capsules workshop, and raw materials workshop
1999
1997
Nanjing Chang Ao was established and engaged in the manufacture and sales of own branded products.
1997
1995
C&O was established and engaged in the manufacture and sales of own branded products and distribution of third parties’ products
1995
Address5/F, Jihao Building, 1086 Shennan East Road, Luohu District, Shenzhen
Adverse drug reactions / Event feedback hotline025-6816 1304
Adverse drug reactions / Event feedback mailGVP@changao.com
Address5/F, Jihao Building, 1086 Shennan East Road, Luohu District, Shenzhen
Adverse drug reactions / Event feedback hotline025-6816 1304
Adverse drug reactions / Event feedback mailGVP@changao.com
Official WeChat account